Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -62.37% vs 38.54% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 106.52% vs -8.61% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -32.55% vs 131.30% in Mar 2024
Compare Balance Sheet Results of Vilin Bio Med
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.95
6.44
7.51
116.61%
Share Warrants & Outstandings
Total Reserve
9.11
15.92
-6.81
-42.78%
Shareholder's Funds
23.06
22.36
0.70
3.13%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.09
0.09
0.00
0.00%
Other Long Term Liabilities
0.00
0.48
-0.48
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.09
0.57
-0.48
-84.21%
Current Liabilities
Trade Payables
1.39
3.26
-1.87
-57.36%
Other Current Liabilities
0.61
2.24
-1.63
-72.77%
Short Term Borrowings
2.57
7.41
-4.84
-65.32%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
4.57
12.91
-8.34
-64.60%
Total Liabilities
27.73
35.83
-8.10
-22.61%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
9.39
11.24
-1.85
-16.46%
Less: Accumulated Depreciation
8.11
6.65
1.46
21.95%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.28
4.59
-3.31
-72.11%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.57
0.00
1.57
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
5.06
5.07
-0.01
-0.20%
Other Non Current Assets
7.26
0.00
7.26
0.00%
Total Non-Current Assets
15.17
9.66
5.51
57.04%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.41
6.07
-1.66
-27.35%
Sundry Debtors
6.31
12.24
-5.93
-48.45%
Cash and Bank
0.06
7.23
-7.17
-99.17%
Other Current Assets
1.08
0.00
1.08
0.00%
Short Term Loans and Advances
0.70
0.64
0.06
9.37%
Total Current Assets
12.56
26.17
-13.61
-52.01%
Net Current Assets (Including Current Investments)
7.99
13.27
-5.28
-39.79%
Total Current Assets Excluding Current Investments
12.56
26.17
-13.61
-52.01%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
27.73
35.83
-8.10
-22.61%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
2.57
7.41
-4.84
-65.32%
Book Value per share (adjusted)
16.53
34.73
-18.20
-52.40%
Annual - Borrowings
Borrowings 2.57 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -62.37% vs 38.54% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 2.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 106.52% vs -8.61% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 12.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -32.55% vs 131.30% in Mar 2024






